eli lilly zepbound news - Search News

Food and Drug Administration, Lilly

Barron's on MSN · 15h

Eli Lilly’s Weight-Loss Drugs No Longer In Shortage. It’s Bad News for These Stocks.

Eli Lilly’s blockbuster obesity and diabetes drugs Zepbound and Mounjaro are no longer in shortage, according to the Food and Drug Administration.It’s a sign that pharmaceutical firm Lilly is making strides to improve the supply issues that have plagued the sector.

USA Today · 7h

Mounjaro, Zepbound shortage eases as supplies of weight loss drug rebound

Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit cheaper copycat versions.

The Wall Street Journal on MSN · 4h

Eli Lilly’s Weight-Loss, Diabetes Drug Shortages Are Over, FDA Says

The removal of Zepbound and Mounjaro from the regulator’s shortage list could lead to restrictions on pharmacies making custom-made versions.

12h

Mounjaro and Zepbound Are No Longer in Shortage, F.D.A. Says

The change will expand access to the diabetes and weight-loss drugs. But it will also complicate the future of compounded ...

ConsumerAffairs9h

Mountjaro, Zepbound removed from FDA's shortage list

The FDA has removed two of Eli Lilly's in-demand weight-loss and diabetes drugs from its shortage list. Diabetes drug ...

17hon MSN

Eli Lilly plans $4.5 billion facility in LEAP District, bringing investment to $13 billion

The $4.5 billion investment will create the Lilly Medicine Foundry, a center that will combine research and manufacturing ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results